Dual Trigger Protocol

Dual Trigger (Double Trigger) – Detailed Clinical Protocol

What is Dual Trigger?

Dual trigger is the co-administration of GnRH agonist and hCG hormones to enhance oocyte maturation. The aim is to obtain more mature (MII) oocytes.

In Which Patients Is It Preferred?

• Low mature oocyte rate
• Oocyte maturation problem in previous cycle
• Borderline responder
• Some poor responder patients

Basic Principle

GnRH agonist → triggers endogenous LH + FSH peak
hCG → supports luteinization
This combination provides a more physiological mimicry of ovulation.

Standard Dual Trigger Timing

• Administered when follicles are 17–20 mm
• OPU performed 34–36 hours later

Drug Combinations

1. GnRH agonist (e.g., triptorelin 0.2 mg)
2. hCG (1000–2500 IU low dose or 5000 IU in selected patients)

Protocol Options

• GnRH agonist + low dose hCG (most common)
• GnRH agonist + standard hCG
• Split dose hCG (alternative)

Application Steps

1. Final ultrasound → appropriate follicle size
2. Dual trigger administered on the same day
3. OPU 34–36 hours later

Advantages

• Higher MII oocyte rate
• Better embryo quality
• More physiological hormonal response

OHSS Risk

OHSS risk is minimized with low-dose hCG.
Should be used cautiously in high-risk patients.

Luteal Phase Management

Luteal phase support is important after dual trigger.
Progesterone ± low-dose hCG or estradiol can be added.

Who Benefits Most?

• Patients with oocyte maturation problems
• Low fertilization rate
• Recurrent IVF failure

Clinical Tips

• hCG dose should be adjusted per patient
• If OHSS risk exists, only agonist may be considered
• Freeze-all strategy can be evaluated

Conclusion

Dual trigger is an important strategy that improves oocyte quality and IVF success in selected patients. It should be applied individually.